Proteus and Degussa Announce Successful Milestone Achievement.Business Editors & Health/Medical Writers BIOWIRE2K NIMES, France & DUESSELDORF, Germany--(BUSINESS WIRE)--Nov. 19, 2002 Proteus and Degussa today announced the advancement into manufacturing scale-up of a novel biocatalyst bi·o·cat·a·lyst n. A substance, especially an enzyme, that initiates or modifies the rate of a chemical reaction in a living body; a biochemical catalyst. bi for the production of high performance products for cosmetics, personal care and industrial application. Some of the results of the ongoing partnership between Proteus and Degussa, commenced in early 2001, have recently been published in Organic Process Research and Development, a peer-reviewed scientific journal. "This was an extremely challenging project, as Degussa demanded much improved enzyme properties in specific key characteristics" said Daniel Dupret, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Proteus. "The rapid discovery of this novel enzyme demonstrates the power and efficiency of our proprietary technologies and how rewarding the access to Proteus unique collection of extremophilic micro-organisms can be. The use of Phenomics(TM) for functional genomics combined with our proprietary CLIPS-O(TM) chemistry has enabled Proteus to deliver the expected biocatalyst within timeline and budget". Dr. Stefan Buchholz, Head of Project House Biotechnology at Degussa, said, "We are delighted with our collaboration with Proteus. This new enzyme for manufacturing high performance specialty chemicals is reinforcing our worldwide leadership in this field. The results validate our belief that the technology platform of Proteus is one of the best in the world today for discovering and improving enzymes. We are confident that our relationship will lead to other premium products in the future.'' Proteus is a leading biotech company discovering and developing novel biomolecules This page aims to list articles on Wikipedia that describe particular biomolecules or types of biomolecules. This list is not necessarily complete or up to date - if you see an article that should be here but isn't (or one that shouldn't be here but is), please update the page for pharmaceuticals, cosmetics, fine chemicals, agrochemical agrochemical Any chemical used in agriculture, including chemical fertilizers, herbicides, and insecticides. Most are mixtures of two or more chemicals; active ingredients provide the desired effects, and inert ingredients stabilize or preserve the active ingredients or aid and other industrial applications. The company's activities are supported by specialist know-how and a portfolio of proprietary elements. This portfolio includes a unique proprietary microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. biodiversity with a vast collection of micro-organisms originating from extreme environments and proprietary technologies for functional high throughput screening (Phenomics(TM), CLIPS-O(TM)) and directed evolution (L-Shuffling(TM)). Degussa is an entirely newly-formed, multinational corporation multinational corporation, business enterprise with manufacturing, sales, or service subsidiaries in one or more foreign countries, also known as a transnational or international corporation. These corporations originated early in the 20th cent. consistently aligned to highly profitable specialty chemistry. With sales of EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 12.9 billion and a workforce of some 53,400, it is Germany's third-largest chemical company and world market leader in specialty chemicals. In fiscal 2001, the corporation generated operating profits (EBITA EBITA Earnings Before Interest Taxes Amortization ) of more than EUR1 billion. Degussa's core strength lies in highly-effective system solutions tailored to the requirements of its customers in over 100 countries throughout the world. Its activities are led by the vision "Everybody benefits from a Degussa product - every day and everywhere". |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion